Papillomavirus detection: Demographic and behavioral characteristics influencing the identification of cervical disease

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 2, 2000, Pages 257-264

  Adam, Ervin ^a,b   Berkova, Zuzana ^a   Daxnerova, Zuzana ^a   Icenogle, Joseph ^c   Reeves, William C ^c   Kaufman, Raymond H ^b  

^a Division of Molecular Virologya   (United States)

^b Department of Obstetrics and Gynecology ^*  (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cervical intraepithelial neoplasia; Human papillomavirus; Polymerase chain reaction; Risk factors; Screening

Indexed keywords

VIRUS DNA;

ADULT; AGE; ARTICLE; CANCER GRADING; CANCER SCREENING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

EID: 0346213503     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(00)70208-0     Document Type: Article

References (38)

1. 1. Kiviat NB, Koutsky LA. Specific human papillomavirus types as the causal agents of most cervical intraepithelial neoplasia: implications for current views and treatment. J Natl Cancer Inst 1993;85:934-5.
2. 2. Wright TC, Kurman RT. A critical review of the morphologic classification system of preinvasive lesions of the cervix: the scientific basis for shifting the paradigm. Papillomavirus Rep 1994;5:175-82.
3. 3. Kaufman RH, Adam E, Icenogle J, Lawson H, Lee N, Reeves KO, et al. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1997;176:87-92.
4. 4. Adam E, Kaufman RH, Berkova Z, Icenogle J, Reeves WC. Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia? Am J Obstet Gynecol 1998;178:1235-44.
5. 5. Kaufman RH. Atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion: diagnostic criteria and management. Am J Obstet Gynecol 1996;175 (4 Pt 2):1120-8.
6. 6. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. Cancer cells 7: molecular diagnostics of human cancer. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1989. p. 209-14.
7. 7. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265:472-7.
8. 8. van den Brule AJ, Meijer CJ, Bakels V, Kenemans P, Walboomers JM. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol 1990;28:2739-43.
9. 9. Rymark P, Forslund O, Hansson BG, Lindholm K. Genital HPV infection not a local but a regional infection: experience from a female teenage group. Genitourin Med 1993;69:18-22.
10. 10. Forslund O, Hansson BG, Rymark P, Bjerre B. Human papillomavirus DNA in urine samples compared with that in simultaneously collected urethra and cervix samples. J Clin Microbiol 1993;31:1975-9.
11. 11. Brookmyer R, Gall MH. AIDS epidemiology: a quantitative approach. New York: Oxford University Press; 1994. p. 147-69.
12. 12. Smits HL, Bollen LJ, Tjong-A-Hung SP, Vonk J, Van Der Velden J, Ten Kate FJ, et al. Intermethod variation in detection of human papillomavirus DNA in cervical smears. J Clin Microbiol 1995;33:2631-6.
13. 13. Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R, et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol 1996;34: 2095-100.
14. 14. Wheeler CM, Greet CE, Becket TM, Hunt WC, Anderson SM, Manos MM. Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol 1996;88:261-8.
15. 15. Evander M, Edlund K, Gustafsson A, Jonsson M, Karlsson R, Rylander E, et al. Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis 1995;171:1026-30.
16. 16. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greet CE, Zhang T, et al. Persistence of type specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-43.
17. 17. Pontén J, Adami HO, Bergström R, Dillner J, Friberg LG, Gustafsson L, et al. Strategies for global control of cervical cancer. Int J Cancer 1995;60:1-26.
18. 18. Richart RM. A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol 1990;75:131-3.
19. 19. Koss LG, Durfee GR. Unusual patterns of squamous epithelium of the uterine cervix: cytologic and histologic study of koilocytic atypia. Ann NY Acad Sci 1956;63:1245-61.
20. 20. Koss LG. Cytologic and histologic manifestation of human papillomavirus infection of the female genital tract and their clinical significance. Cancer 1987;60:1942-50.
21. 21. Meisels A, Morin C. Human papillomavirus and cervical lesions. Gynecol Oncol 1981;12(2 Pt 2):S111-23.
22. 22. Boon ME, Kok LP. Koilocytic lesions of the cervix: the interrelation of morphometric features, the presence of papillomavirus antigens and the degree of koilocytosis. Histopathology 1985;9:751-63.
23. 23. Kühler-Obbarius C, Milde-Langosch K, Löning T, Stegner HE. Polymerase chain reaction-assisted evaluation of low and high grade squamous intraepithelial lesion cytology and reappraisal of the Bethesda System. Acta Cytol 1994;38:681-6.
24. 24. Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, et al. Human papillomavirus testing in primary cervical screening. Lancet 1995;345:1533-6.
25. 25. Downey GP, Bavin PJ, Deery AR, Crow J, Griffiths PD, Emery VC, et al. Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease. Lancet 1994;344:432-5.
26. 26. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
27. 27. van Oortmarssen GJ, Habbema JD. Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer 1991;64:559-65.
28. 28. Schneider A, Zahm DM, Greinke C, Kirchmayr R, Nindl I. Different detectability of high-risk HPV in smears from incident and prevalent high-grade squamous intraepithelial lesions of the cervix. Gynecol Oncol 1997;65:399-404.
29. 29. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991;184:9-13.
30. 30. zur Hausen H. Are human papillomavirus infections not necessary or sufficient causal factors for invasive cancer of the cervix? [letter] Int J Cancer 1995;63:315-6.
31. 31. Pontén J, Adami HO, Friberg LG, Gustafsson L, Miller AB, Parkin M, et al. HPV and cervical cancer [letter]. Int J Cancer 1995;63:317.
32. 32. Vonka V, Kaňka J, Jelínek J, Subrt I, Suchánek A, Havránková A, et al. Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. I. Epidemiological characteristics. Int J Cancer 1984;33:49-60.
33. 33. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasm. J Natl Cancer Inst 1993;85:958-64.
34. 31. Burger MP, Hollema M, Gouw AS, Pieters WJ, Quint WG. Cigarette smoking and human papillomavirus risk factors with reported clinical cytological abnormality. BMJ 1993;306: 749-52.
35. 35. Brock KF, MacLennan R, Brinton LA, Melnick JL, Adam EA, Mock PA, et al. Smoking and infectious agents and risk of in situ cervical cancer in Sydney, Australia. Cancer Res 1989; 19:1925-8.
36. 36. Simons AM, Van Herckenrode CM, Rodriguez JA, Maitland N, Anderson M, Phillips DM, et al. Demonstration of smoking-related DNA damage in cervical epithelium and correlation with human papillomavirus type 16 using exfoliated cervical cells. Br J Cancer 1995;71:246-9.
37. 37. Brisson J, Morin K, Fortier M, Roy M, Bouchard C, Leclerc J, et al. Risk factors for cervical intra-epithelial neoplasia: differences between low and high-grade lesions. Am J Epidemiol 1994;140:700-10.
38. 38. Brinton LA, Reeves WC, Brenes MM, Herrero R, de Britton RC, Gaitan E, et al. Parity as a risk factor for cervical cancer. Am J Epidemiol 1989;130:486-96.